Earlier this year, Rhaeos won MedTech Innovator’s 2020 Global Competition. In a recent conversation with Rhaeos CEO Anna Lisa Somera, Somera discussed the significance of the award and how FlowSense can improve the way hydrocephalus is managed.
In this educational blog, Marvin Sussman, PhD, compares the evolution of the cardiac pacemaker and radiation oncology with that of the shunt to treat hydrocephalus over a 60 year period.
HA Board Member and former VP of Sales for Medtronic, Ralph Kistler, reflects back on his 20+ year relationship with the Hydrocephalus Association.
The first public-private partnership, called the Medical Device Innovation Consortium (MDIC), will prioritize the needs of the medical device community and fund projects to help simplify the process for medical devices to reach market. The FDA will be a part of the consortium that could potentially assist new developments in shunt technology.
The Wisconsin State Journal reportes on Dr. Josh Medow, a neurosurgeon with the University of Wisconsin Hospital, created a monitor that can detect changes in brain pressure and send signals to a handheld scanner. The device is now heading into animal trials.